Canagliflozin

(1S)-1,5-Anhydro-1-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-D-glucitol, (1S)-1,5-Anhydro-1-c-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol, 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene, Invokana, JNJ 24831754, JNJ 24831754AAA, JNJ 24831754ZAE, TA 7284, UNII-6S49DGR869, D-Glucitol, 1,5-anhydro-1-C-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4- methylphenyl) (1S)-

Canagliflozin is  classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
SMILES:   [H][C,]1(O[C,H](CO)[C,,H](O)[C,H](O)[C,H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1